Analyst Consensus
- Current Price
- 577.22 $
- Target (Low)
- 664.46 $
- Target (Mean)
- 827.32 $
- Target (High)
- 1,015.00 $
- Recommendation
- Strong Buy
- Number of Analysts
- 59
Recommendation Distribution
Recommendation Distribution| Strong Buy | 8 |
|---|
| Buy | 50 |
|---|
| Hold | 6 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 32.8%
- Operating Margin
- 40.6%
- Gross Margin
- 81.9%
- Return on Equity (ROE)
- 32.9%
- Return on Assets (ROA)
- 16.4%
- Revenue Growth
- 33.1%
- Earnings Growth
- 62.4%
- Debt/Equity
- 35.61
- Current Ratio
- 2.35
- Beta
- 1.23
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Sep 30, 2024 | Cantor Fitzgerald | Overweight → Overweight |
| Sep 30, 2024 | Monness, Crespi, Hardt | Buy → Buy |
| Sep 26, 2024 | Rosenblatt | Buy → Buy |
| Sep 26, 2024 | B of A Securities | Buy → Buy |
| Sep 26, 2024 | JP Morgan | Overweight → Overweight |
| Sep 26, 2024 | Wedbush | Outperform → Outperform |